港股午评：恒指跌0.04%、科指跌0.66%，内房股、新消费概念股走强，科网股、商业航天及生物医药股下挫

Market Overview - The Hong Kong stock market opened high but experienced a decline, with the Hang Seng Index down 0.04% at 26,552.57 points, the Hang Seng Tech Index down 0.66% at 5,712.19 points, and the National Enterprises Index down 0.12% at 9,123.18 points, while the Red Chip Index rose 1% to 4,183.81 points [1] - Major tech stocks generally fell, with Alibaba down 0.25%, Tencent down 1.48%, and Xiaomi down 1.48%, while JD.com rose 1.07% and NetEase rose 1.85% [1] - Real estate stocks showed strength, with Greentown China rising over 5%, while new consumption concepts were active, with Hu Shang Ayi rising over 10% [1] - The commercial aerospace sector weakened, with Asia Pacific Satellite down over 6%, and the biopharmaceutical sector continued to adjust, with WuXi AppTec down over 4% [1] Corporate News - Code-B (02487.HK) reported positive top-line results from a Phase III clinical trial for CU-20101, an injectable type A botulinum toxin for moderate to severe glabellar lines [2] - Saint Bella (02508.HK) signed a strategic cooperation framework agreement with Cloud Technology to explore the integration of AI and robotics in high-demand home care scenarios [2] - China Pacific Insurance (00966.HK) expects a net profit increase of approximately 215% to 225% in 2025, compared to 8.432 billion HKD in the previous year [2] - TCL Electronics (01070.HK) anticipates an adjusted net profit of approximately 2.33 to 2.57 billion HKD in 2025, representing a growth of about 45% to 60% [2] - Jihong Co. (02603.HK) expects a net profit of approximately 273 to 291 million HKD in 2025, a year-on-year increase of 50% to 60% due to growth in packaging and cross-border e-commerce [2] - Guolian Minsheng (01456.HK) expects a net profit of approximately 2.008 billion RMB in 2025, a year-on-year increase of around 406% [2] - China Railway (00390.HK) reported a new contract amount of 1,165.98 billion RMB in Q4 2025, with a cumulative new contract amount of 2,750.9 billion RMB, a year-on-year increase of 1.3% [2] Additional Corporate Updates - Shenzhen Holdings (00604.HK) expects a total contract sales amount of approximately 13.311 billion RMB in 2025, a decrease of 21.55% year-on-year [3] - SF Holding (06936.HK) reported a total revenue of 27.339 billion RMB in December from its express logistics, supply chain, and international business, a year-on-year increase of 3.41% [4] - China Ruyi (00136.HK) plans to invest approximately 14.2 million USD in AIsphere to explore AI applications in film, streaming, and gaming content production [4] - Baide International (02668.HK) signed a memorandum of understanding with potential sellers regarding the possible acquisition of part or all of a target company's equity [5] - HAPO (02142.HK) exercised warrants under an agreement with Spruce [6] - Yuanda Pharmaceutical (00512.HK) had its new drug application for TLX591-CDx accepted by the Chinese drug regulatory authority [7] - Yancoal Australia (03668.HK) reported a coal production of 10.4 million tons in Q4 2025, a 12% increase quarter-on-quarter and a 7% increase year-on-year [7] Institutional Insights - Dongwu Securities noted that the Hong Kong market is in a long-term upward trend but faces short-term challenges, with strong consensus on domestic fundamentals but mixed views on overseas factors [8] - Huaxia Fund highlighted the high sensitivity of the Hong Kong market to corporate earnings and macroeconomic data, suggesting that positive economic surprises could significantly boost market expectations [8] - Citigroup expressed optimism about the Hong Kong market's prospects compared to A-shares, anticipating support from both southbound and foreign capital in 2026, while cautioning against potential risks from high overseas interest rates [8] - Guolian Minsheng Securities remains bullish on the revaluation of AI in China, citing a solid industrial catalyst timeline and upcoming model releases from major companies [8]